| Old Articles: <Older 23401-23410 Newer> |
|---|
 |
The Motley Fool
May 22, 2007
Rick Aristotle Munarriz |
The Day My Satellite Radio Died Degradation is nothing new at XM. The way that XM buckled under pressure last week, making it seem almost terrestrial, will sting far longer than this week's outage. Investors, take note.   |
The Motley Fool
May 22, 2007
Anders Bylund |
Foolish Forecast: Up and Away With Gymboree The children's apparel retailer is set to release its quarterly earnings. Investors, here is what you can expect to see. |
The Motley Fool
May 22, 2007 |
NetEase's Westward Journey: Fool by Numbers The Chinese Internet concern released its first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
May 22, 2007 |
Hastings Wasting Away: Fool by Numbers The entertainment company released its first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
May 22, 2007
Mike Havrilla |
An Emergent Opportunity The vaccine developer guided for revenue growth of 10% to 15% for this year. Emergent also has a strong balance sheet, with more than $67 million in cash and investments. Investors, take note. |
The Motley Fool
May 22, 2007
Tom Taulli |
Alltel's New Private Equity Plan The small wireless operator gets a juicy premium in buyout. For wise investors, it's probably best to take your winnings off the table. |
The Motley Fool
May 22, 2007
Steven Mallas |
Campbell's Savory Quarter Campbell Soup's third quarter was quite satisfying. The company has come a long way from the dark days when growth was challenged and, more ominously, a dividend cut was enacted. |
The Motley Fool
May 22, 2007
Rick Aristotle Munarriz |
Home Inns and Outs China's value-priced lodging chain checks in nicely, but not cheaply for investors. |
The Motley Fool
May 22, 2007
Rick Aristotle Munarriz |
China's World of Wow Craft Not long ago, The9 was a low-profile company that earned its keep by distributing titles in mainland China that were made by South Korea's WebZen. Now it has a compelling pipeline in the works to make sure it doesn't have too much riding on World of Warcraft. Investors, take note. |
The Motley Fool
May 22, 2007
Mike Havrilla |
Coley Gets a Cold Reception The market cares little for this drug developer's promising prospects, but some investors like this pharma at it current $230 million market cap, given the company's strong partnerships. |
| <Older 23401-23410 Newer> Return to current articles. |
